CClinicalTrials.gg
Active, not recruitingNCT07514377Updated Apr 7, 2026

JiGenerations Health Cohort Study:Parental Exposure and Intergenerational Health in China

An observational study in Environmental Exposure, Fertility and Health Problems in Pregnancy, sponsored by National Research Institute for Family Planning, China. Active, not recruiting at 1 site in China. Open to participants aged 1 Day to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-07.

Sponsored by National Research Institute for Family Planning, China · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100,000
Ages
1 Day to 45 Years
Sex
All
01

Study summary

The growing recognition of maternal health's impact on offspring necessitates large-scale prospective cohort studies spanning the maternal-child life cycle. This study establishes a family-centered birth cohort of 100,000 Chinese participants, tracking from preconception through offspring adolescence to investigate early-life health trajectories and intergenerational transmission of diseases, health status, and psychological-behavioral patterns. Data collection includes biospecimens (placenta, cord blood, breast milk, blood, urine, feces) and multi-omics analysis (genomic, proteomic, metabolomic, microbiomic), alongside clinical information from preconception, pregnancy, birth through childhood (0-14 years). The cohort covers 24 stratified sites across China, incorporating real-time environmental monitoring (air pollution, meteorological data) and sociogeographic factors. Targeting reproductive-age couples (18-45 years) and their offspring, the study addresses multigenerational health linkages, urban-rural disparities, and regional diversity from 2025 to 2039. By integrating genetic, environmental and lifestyle data, this research will identify critical intervention windows and mechanisms for chronic disease transmission across generations, supporting China's "Healthy China" initiative and developing targeted strategies for population health and aging.

Read the detailed description

The impact of maternal conditions on offspring health and disease has garnered increasing attention, underscoring the necessity of large-scale, prospective, multicenter cohort studies spanning the entire maternal-child life cycle to elucidate this relationship.

This study aims to establish a family-centered birth cohort of 100,000 individuals, beginning at the preconception stage and tracking offspring through adolescence, to investigate early-life health trajectories. By doing so, we seek to enhance understanding of the intergenerational transmission of disease, health status, longevity, and psychological-behavioral patterns in the Chinese population. Furthermore, this research will identify critical intervention windows and underlying mechanisms, enabling the development of targeted health interventions. Ultimately, these efforts will contribute to improved population health and the advancement of healthy aging strategies rooted in early-life interventions.

Data and Biospecimen Collection Information and biological samples will be collected from couples before conception, during pregnancy, at birth, and throughout childhood (0-14 years), establishing a family-centered cohort spanning preconception, pregnancy, birth, and childhood.

Key health outcomes include metabolic disorders, cardiovascular diseases, neurodevelopmental abnormalities, immune-related conditions, and mental health issues.

Multi-Omics Biobank A comprehensive database will be built using biospecimens such as placenta, umbilical cord blood, umbilical tissue, breast milk, oral epithelial cells, blood, urine, and feces, integrating genomic, proteomic, metabolomic, and microbiomic data.

Study Population and Timeline The target population consists of Chinese couples of reproductive age (18-49 years) and their offspring, with a focus on multigenerational health linkages, urban-rural disparities, and regional representation.

The study will launch in 2025, with long-term follow-up until 2039, conducted in phases from preconception to offspring adolescence.

Geographical and Environmental Coverage A stratified sampling approach will cover 24 research sites across Northwest, Southwest, Central, North, East, South, and Northeast China, ensuring diversity in climate, socioeconomic status, and pollution levels.

Real-time air pollution monitoring (e.g., PM2.5, SO₂), meteorological data (temperature, humidity), and sociogeographic factors (green space, urbanization) will be included.

Significance: By integrating genetic, environmental, and lifestyle data, this study will uncover how early-life exposures influence chronic disease transmission across generations, providing targeted intervention strategies to support China's "Healthy China" initiative and address aging-related challenges.

02

Conditions studied

  • Environmental Exposure
  • Fertility
  • Health Problems in Pregnancy
  • Adverse Pregnancy Outcomes
  • Birth Defects
  • Child Development
  • Metabolic Abnormality
  • Growth Retardation
  • Overweight and Obesity
  • Non-alcoholic Fatty Liver Disease

Keywords

  • birth cohort study
  • environmental exposures
  • birth defects
  • pregnant outcomes
  • children development
  • Child psychological development
03

In context

Congenital Abnormalities

980 studies on the registry are indexed under Congenital Abnormalities; 177 are open to participants now.

This study's enrollment of 100,000 is above the median of 153 across 446 observational studies indexed under Congenital Abnormalities.

Browse Congenital Abnormalities studies →

Lead sponsor

National Research Institute for Family Planning, China is the lead sponsor of 4 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Day to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

The participants come from 24 survey sites in the northwest, southwest, central, northern, eastern, southern, and northeastern regions, include parental and offspring generations.

  1. Parental Generation: Eligible participants include couples of reproductive age who undergo free pre-pregnancy eugenic health examinations, or pregnant women registered for prenatal care at healthcare institutions during early pregnancy (≤14 weeks).
  2. Offspring Generation: Newborns whose parents participated in pre-pregnancy eugenic health checks and/or maternal prenatal examinations are enrolled in the cohort upon parental (guardian) consent.

Inclusion criteria

  1. Parental Generation: Eligible participants include couples of reproductive age who undergo free pre-pregnancy eugenic health examinations, or pregnant women registered for prenatal care at healthcare institutions during early pregnancy (≤14 weeks). The participants are aged 18-45 years old and have mobile phones and internet (computer) devices. All participants must provide informed consent and commit to long-term follow-up. The participants have no serious neuropsychiatric disorders, with sufficient understanding and expression to complete the survey.
  2. Offspring Generation: Newborns whose parents participated in pre-pregnancy eugenic health checks and/or maternal prenatal examinations are enrolled in the cohort upon parental (guardian) consent. Designated hospitals will provide expedited medical services, free physical examinations, free child healthcare, and free psychological counseling to ensure comprehensive follow-up spanning infancy, preschool, school age, and early adolescence (0-14 years).

Exclusion criteria

Exclusion Criteria:

  1. Intellectual disability or other serious mental disorders;
  2. Suffering from serious underlying diseases and may have a significant impact on pregnancy outcome;
  3. Those with poor compliance and difficulty in follow-up.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100,000 participants (actual)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Condition or exposure

    individuals with Condition or exposure.

    Other: N/A (Observational Study)

  • Non-Condition or exposure

    individuals without Condition or exposure.

    Other: N/A (Observational Study)

Interventions

  • OtherN/A (Observational Study)

    This is an observational cohort study. No interventions are assigned. Groups are defined based on different condition or exposure.

06

What researchers measure

Primary outcomes

  1. Adverse pregnancy outcomes

    the rate of different adverse pregnancy outcomes

    Time frame: At delivery

Secondary outcomes

  1. Complications during pregnancy

    The rate of maternal nutritional and pathological health issues.

    Time frame: From enrollment during pregnancy until delivery or pregnancy termination, up to 40 weeks

  2. Associations between prenatal environmental exposures and offspring health outcomes

    The Odds Ratio for offspring health outcomes in different prenatal environmental exposures.

    Time frame: at baseline (preconception), during pregnancy (12weeks,24weeks and 32weeks), at delivery, and during offspring follow-up visits (at 3 months,6 months,9months, and 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 years)

07

Study locations

1 site
  • National Research Institute for Family Planning
    Beijing, Beijing Municipality, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07514377
Lead sponsor
National Research Institute for Family Planning, China
Collaborators
West China Second University Hospital
Responsible party
Yuan He (Principal Investigator, National Research Institute for Family Planning, China) — Principal investigator
First posted
Apr 7, 2026
Start date
Aug 1, 2025
Primary completion
Dec 31, 2039 (estimated)
Completion
Dec 31, 2039 (estimated)
Last update
Apr 7, 2026

Study contacts

Yuan He
study director · National Centre for Human Genetic Resources, National Research Institute for Family Planning

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion